Evidence map›Paper›PMID 26979476›Full record

ArticlePatient education and counseling2016

Assessing patients' experiences with communication across the cancer care continuum.

Kathleen M Mazor, Richard L Street, Valerie M Sue, Andrew E Williams, Borsika A Rabin, Neeraj K Arora

2 registry-linked trialsAbstract read
In one paragraph

Article in Patient education and counseling, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02282722 nacompletednot on this map

Improving Informed Consent for Palliative Chemotherapy: Development of a Regimen-Specific Multi-Media Informed Consent Library To Promote Patient-Centered Decision-Making About Treatment of Advanced Gastrointestinal Cancers

TypeinterventionalSponsorDana-Farber Cancer InstituteRan2015 to 2017Enrolled216ConditionsMetastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Unresectable Pancreatic CancerArmsInvestigational informed consent for chemotherapy, Usual, standard-of-care informed consent for chemotherapy
NCT03602885 nacompletednot on this mapstarted 2018, after this paper: background citation

EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options - RCT of Usual Chemotherapy Educational Tools Versus Investigational Chemotherapy Educational Tools

TypeinterventionalSponsorDana-Farber Cancer InstituteRan2018 to 2020Enrolled10ConditionsMetastatic Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Colorectal CancerArmsUsual chemotherapy education (CE), Chemotherapy education intervention (CEI)
3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kathleen M MazorMeyers Primary Care Institute, 630 Plantation Street, Worcester, MA 01605, USA. Electronic address: Kathy.Mazor@meyersprimary.org.
Richard L StreetDepartment of Communication, Texas A&M University, 456 Ross Street, College Station, TX 77843, USA. Electronic address: r-street@tamu.edu.
Valerie M SueKaiser Permanente, 300 Lakeside Drive, Oakland, CA 94612, USA. Electronic address: valerie.m.sue@kp.org.
Andrew E WilliamsMaine Medical Center Research Institute, 81 Research Drive, Scarborough, ME 04074, USA. Electronic address: aewilliams@mmc.org.
Borsika A RabinDepartment of Family Medicine, University of Colorado-Denver, 13001 E 17th Place, Aurora, CO 80045, USA. Electronic address: borsika.a.rabin@gmail.com.
Neeraj K AroraPatient-Centered Research Outcomes (PCORI) Research Branch, 1828L Street NW #900, Washington, DC 20036, USA. Electronic address: narora@pcori.org.

Funding

Training and DevelopmentP20CA137219 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI DEARING, JAMES WILLIAM · 2008 to 2012
$7.8M
NCI NIH HHS P20 CA137219
6 · The paper itself

Abstract

objectiveTo evaluate the relevance, performance and potential usefulness of the Patient Assessment of cancer Communication Experiences (PACE) items.

methodsItems focusing on specific communication goals related to exchanging information, fostering healing relationships, responding to emotions, making decisions, enabling self-management, and managing uncertainty were tested via a retrospective, cross-sectional survey of adults who had been diagnosed with cancer. Analyses examined response frequencies, inter-item correlations, and coefficient alpha.

resultsA total of 366 adults were included in the analyses. Relatively few selected Does Not Apply, suggesting that items tap relevant communication experiences. Ratings of whether specific communication goals were achieved were strongly correlated with overall ratings of communication, suggesting item content reflects important aspects of communication. Coefficient alpha was ≥.90 for each item set, indicating excellent reliability. Variations in the percentage of respondents selecting the most positive response across items suggest results can identify strengths and weaknesses.

conclusionThe PACE items tap relevant, important aspects of communication during cancer care, and may be useful to cancer care teams desiring detailed feedback. PRACTICE IMPLICATIONS: The PACE is a new tool for eliciting patients' perspectives on communication during cancer care. It is freely available online for practitioners, researchers and others.

Indexed as

CommunicationPatient-Centered CarePatient SatisfactionPhysician-Patient RelationsAdultAgedAged, 80 and overCross-Sectional StudiesHumansMiddle AgedNeoplasmsRetrospective StudiesAssessment of communicationPatient-centered communicationPatient perceptionsPhysician-patient communication

Identifiers

PMID26979476
PMCPMC4931971

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.